SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

ADARx Pharmaceuticals files for Nasdaq Global Market IPO under ADRX

ADARx Pharmaceuticals, a late-clinical stage siRNA therapeutics developer, filed for an initial public offering and plans to list on the Nasdaq Global Market under ticker ADRX.

QQQ

Story updates

09:33:05 PM UTC
SquawkNews
Adarx Pharmaceuticals Announces Initial Public Offering Of Common Stock, SEC Filing

This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.

Related stories